The alternative NF-κB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection

Viral Immunology

Volumn 23, Issue 3, 2010, Pages 295-308

  Droebner, Karoline ^a   Klein, Bettina ^a   Paxian, Stephan ^b   Schmid, Roland ^b   Stitz, Lothar ^a   Planz, Oliver ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; PROTEIN P52; NFKB1 PROTEIN, MOUSE; VIRUS ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; T CELL DEPLETION; T LYMPHOCYTE; VESICULAR STOMATITIS; VESICULAR STOMATITIS VIRUS; ANIMAL; C57BL MOUSE; IMMUNOLOGY; MOUSE MUTANT; SIGNAL TRANSDUCTION;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; VESICULAR STOMATITIS;

EID: 77954171692     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0101     Document Type: Article

References (74)

1. Aichele P, Zinke J, Grode L, et al.: Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J Immunol 2003;171:1148-1155.
2. Banchereau J, Briere F, Caux C, et al.: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
3. Basak S, and Hoffmann A: Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev 2008;19:187-197.
4. Battegay M, Moskophidis D, Rahemtulla A, et al.: Enhanced establishment of a virus carrier state in adult CD4+T-celldeficient mice. J Virol 1994;68:4700-4704.
5. Battegay M, Cooper S, Althage A, et al.: Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods 1991;33: 191-198.
6. Beinke S, and Ley SC: Functions of NF-kappaB1 and NFkappaB2 in immune cell biology. Biochem J 2004;382:393-409.
7. Bonizzi G, and Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288.
8. Bourteele S, Oesterle K, Weinzierl AO, et al.: Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell Microbiol 2007;9:2202-2217.
9. Buchmeier MJ, Welsh RM, Dutko FJ, and Oldstone MB: The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol 1980;30:275-331.
10. Butz E, and Bevan MJ: Dynamics of the CD8+T cell response during acute LCMV infection. Adv Exp Med Biol 1998;452:111-122.
11. Caamano J, Tato C, Cai G, et al.: Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol 2000;165:5720-5728.
12. Caamano J, and Hunter CA: NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clin Microbiol Rev 2002;15:414-429.
13. Caamano JH, Rizzo CA, Durham SK, et al.: Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med 1998;187:185-196.
14. Cardin RD, Brooks JW, Sarawar SR, and Doherty PC: Progressive loss of CD8+T cell-mediated control of a gammaherpesvirus in the absence of CD4+T cells. J Exp Med 1996;184:863-871.
15. Dorries R: The role of T-cell-mediated mechanisms in virus infections of the nervous system. Curr Top Microbiol Immunol 2001;253:219-245.
16. Droebner K, Reiling SJ, and Planz O: Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1 influenza A virus infection. J Virol 2008;82:11461-11466.
17. Franzoso G, Carlson L, Poljak L, et al.: Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J Exp Med 1998;187:147-159.
18. Hayden MS, and Ghosh S: Shared principles in NF-kappaB signaling. Cell 2008;132:344-362.
19. Hoffmann A, and Baltimore D: Circuitry of nuclear factor kappaB signaling. Immunol Rev 2006;210:171-186.
20. Kagi D, Ledermann B, Burki K, et al.: Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol Rev 1995;146:95-115.
21. Kagi D, Ledermann B, Burki K, et al.: Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996;14:207-232.
22. Kagi D, and Hengartner H: Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol 1996;8:472-477.
23. Kalams SA, Buchbinder SP, Rosenberg ES, et al.: Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol 1999;73:6715-6720.
24. Kang SS, and McGavern DB: Lymphocytic choriomeningitis infection of the central nervous system. Front Biosci 2008; 13:4529-4543.
25. Karrer U, Althage A, Odermatt B, et al.: On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11 (-)/-) mutant mice. J Exp Med 1997;185:2157-2170.
26. Kast WM, Boog CJ, Roep BO, et al.: Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. J Immunol 1988;140:3186-3193.
27. Khanolkar A, Fuller MJ, and Zajac AJ: T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol Res 2002;26:309-321.
28. Kraal G: Cells in the marginal zone of the spleen. Int Rev Cytol 1992;132:31-74.
29. Lanzavecchia A, and Sallusto F: Regulation of T cell immunity by dendritic cells. Cell 2001;106:263-266.
30. Lanzavecchia A, and Sallusto F: The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001;13:291-298.
31. Lehmann-Grube F: Persistent infection of the mouse with the virus of lymphocytic choriomeningitis. J Clin Pathol Suppl (R Coll Pathol) 1972;6:8-21.
32. Lehmann-Grube F, and Moskophidis D: Lymphocytic choriomeningitis virus-specific delayed-type hypersensitivity reaction in mice. Adv Exp Med Biol 1989;257:91-107.
33. Lehmann-Grube F, Moskophidis D, and Lohler J: Recovery from acute virus infection. Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice. Ann NY Acad Sci 1988;532:238-256.
34. Leist TP, Cobbold SP, Waldmann H, et al.: Functional analysis of T lymphocyte subsets in antiviral host defense. J Immunol 1987;138:2278-2281.
35. Li Q, and Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725-734.
36. Lind EF, Ahonen CL, Wasiuk A, et al.: Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens. J Immunol 2008;181:354-363.
37. Liu YJ, Johnson GD, Gordon J, and MacLennan IC: Germinal centres in T-cell-dependent antibody responses. Immunol Today 1992;13:17-21.
38. Ludewig B, Ehl S, Karrer U, et al.: Dendritic cells efficiently induce protective antiviral immunity. J Virol 1998;72:3812-3818.
39. Ludwig S, and Planz O: Influenza viruses and the NFkappaB signaling pathway-towards a novel concept of antiviral therapy. Biol Chem 2008;389:1307-1312.
40. Luo JL, Kamata H, and Karin M: IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 2005;115:2625-2632.
41. Macatonia SE, Taylor PM, Knight SC, and Askonas BA: Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 1989;169:1255-1264.
42. MacLennan IC: Germinal centers. Annu Rev Immunol 1994; 12:117-139.
43. Marsland BJ, Bättig P, Bauer M, et al.: CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 2005;4:493-505.
44. MartIn-Fontecha A, Sebastiani S, Höpken UE, Uguccioni M, Lipp M, Lanzavecchia A, and Sallusto F: Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med 2003; 198:615-621.
45. Matloubian M, Concepcion RJ, and Ahmed R: CD4+T cells are required to sustain CD8+cytotoxic T-cell responses during chronic viral infection. J Virol 1994;68:8056-8063.
46. Mazur I, Wurzer WJ, Ehrhardt C, et al.: Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NFkappaB- inhibiting activity. Cell Microbiol 2007;9:1683-1694.
47. McGavern DB, Homann D, and Oldstone MB: T cells in the central nervous system: the delicate balance between viral clearance and disease. J Infect Dis 2002;186(Suppl 2):S145-S151.
48. Mims CA, and Blanden RV: Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus. Infect Immun 1972;6:695-698.
49. Moore F, Buonocore S, Aksoy E, et al.: An alternative pathway of NF-kappaB activation results in maturation and T cell priming activity of dendritic cells overexpressing a mutated IkappaBalpha. J Immunol 2007;178:1301-1311.
50. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866.
51. Moskophidis D, and Lehmann-Grube F: Virus-induced delayed-type hypersensitivity reaction is sequentially mediated by CD8+and CD4+T lymphocytes. Proc Natl Acad Sci USA 1989;86:3291-3295.
52. Moskophidis D, Fang L, Gossmann J, et al.: Virus-specific delayed-type hypersensitivity (DTH). Cells mediating lymphocytic choriomeningitis virus-specific DTH reaction in mice. J Immunol 1990;144:1926-1934.
53. Muller S, Hunziker L, Enzler S, Buhler-Jungo M, Di Santo JP, Zinkernagel RM, and Mueller C: Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production. J Virol 2000;76:2375-2383.
54. Oldstone MB: Molecular anatomy of viral persistence. J Virol 1991;65:6381-6386.
55. Oldstone MB: Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol 2002;263:83-117.
56. Oldstone MB, and Dixon FJ: Susceptibility of different mouse strains to lymphocytic choriomeningitis virus. J Immunol 1968;100:355-357.
57. Oldstone MB, Buchmeier MJ, Doyle MV, and Tishon A: Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection. J Immunol 1980;124:831-838.
58. Ostler T, Schamel K,Hussell T, et al.: An improved protocol for measuring cytotoxic T cell activity in anatomic compartments with low cell numbers. J Immunol Methods 2001;257:155-161.
59. Pahl HL: Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999;18:6853-6866.
60. Paxian S, Merkle H, Riemann M, et al.: Abnormal organogenesis of Peyer's patches in mice deficient for NF-kappaB1, NF-kappaB2, and Bcl-3. Gastroenterology 2002;122:1853-1868.
61. Peacock CD, and Welsh RM: Origin and fate of lymphocytic choriomeningitis virus-specific CD8+T cells coexpressing the inhibitory NK cell receptor Ly49G2. J Immunol 2004;173: 478-484.
62. Pereira SG, and Oakley F: Nuclear factor-kappaB1: regulation and function. Int J Biochem Cell Biol 2008;40:1425-1430.
63. Poljak L, Carlson L, Cunningham K, et al.: Distinct activities of p52/NF-kappa B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J Immunol 1999;163:6581-6588.
64. Santoro MG, Rossi A, and Amici C: NF-kappaB and virus infection: who controls whom. EMBO J 2003;22:2552-2560.
65. Schmid JA, and Birbach A: IkappaB kinase beta (IKKbeta/ IKK2/IKBKB)-a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev 2008;19:157-165.
66. Seiler P, Aichele P, Odermatt B, et al.: Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol 1997;27:2626-2633.
67. Tew JG, Wu J, Fakher M, et al.: Follicular dendritic cells: beyond the necessity of T-cell help. Trends Immunol 2001;22:361-367.
68. Veerman KM, Williams MJ, Uchimura K, et al.: Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs. Nat Immunol 2007;8:532-539.
69. Verhasselt V, Vanden Berghe W, Vanderheyde N, et al.: N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol 1999;162:2569-2574.
70. Xu MQ, Suo YP, Gong JP, et al.: Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol 2004; 10:2361-2368.
71. Yamamoto M, and Takeda K: Role of nuclear IkappaB proteins in the regulation of host immune responses. J Infect Chemother 2008;14:265-269.
72. Yoshimura S, Bondeson J, Brennan FM, et al.: Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 2001;31:1883-1893.
73. Zinkernagel RM: Lymphocytic choriomeningitis virus and immunology. Curr Top Microbiol Immunol 2002;263: 1-5.
74. Zinkernagel RM, and Doherty PC: Cytotoxic thymus-derived lymphocytes in cerebrospinal fluid of mice with lymphocytic choriomeningitis. J Exp Med 1973;138:1266-1269.